Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer

(2018) Jaynish S. Shah et al.   GYNECOLOGIC ONCOLOGY

A combination of circulating miRNAs for the early detection of ovarian cancer

(2017) Akira Yokoi et al.   Oncotarget

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer

(2016) F. Leung et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602

(2016) Takashi Onda et al.   EUROPEAN JOURNAL OF CANCER

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

(2016) Ian J Jacobs et al.   LANCET

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

(2016) Koji Nakamura et al.   Molecular Cancer

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

(2016) Koji Nakamura et al.   MOLECULAR CANCER RESEARCH

TRPM7 is required for ovarian cancer cell growth, migration and invasion

(2014) Jing Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer

(2014) BEI WANG et al.   ONCOLOGY REPORTS

Circulating Exosomal microRNAs as Biomarkers of Colon Cancer

(2014) Hiroko Ogata-Kawata et al.   PLoS One

MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls

(2013) A. Li et al.   CLINICAL CANCER RESEARCH

TC-1 (C8orf4) expression is correlated with differentiation in ovarian carcinomas and might distinguish metastatic ovarian from metastatic colorectal carcinomas

(2013) Hong-Tao Xu et al.   VIRCHOWS ARCHIV

Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells

(2012) Jia Wu et al.   CANCER LETTERS

Purified autoantibodies against glucose-regulated protein 78 (GRP78) promote apoptosis and decrease invasiveness of ovarian cancer cells

(2011) Marie Cohen et al.   CANCER LETTERS

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

(2010) Ignace Vergote et al.   NEW ENGLAND JOURNAL OF MEDICINE

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers

(2009) Chunqiao Tian et al.   CANCER

The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass

(2009) Martina Montagnana et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

(2008) Douglas D. Taylor et al.   GYNECOLOGIC ONCOLOGY

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

(2008) Johan Skog et al.   NATURE CELL BIOLOGY

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY